Question 1

Is there a generic for Suzetrigine?

Accepted Answer

The FDA Orange Book does not currently list an approved generic (ANDA) for Suzetrigine. It is available as 1 brand (NDA) application.

Question 2

What is the reference-listed drug for Suzetrigine?

Accepted Answer

JOURNAVX (NDA 219209, VERTEX PHARMS INC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

Question 3

What patents protect Suzetrigine?

Accepted Answer

The Orange Book lists 1 patent against Suzetrigine products, with the earliest listed expiry in 2040. Listed patents cover the drug substance, drug product, or approved methods of use, and a generic launching before they expire must file a Paragraph IV certification.

Question 4

Does Suzetrigine have FDA marketing exclusivity?

Accepted Answer

Yes. The Orange Book records 1 marketing-exclusivity period for Suzetrigine. Exclusivity is granted by FDA at approval (for example new-chemical-entity, orphan-drug, or pediatric exclusivity) and runs independently of any listed patents.

Question 5

What dosage forms of Suzetrigine are approved?

Accepted Answer

Suzetrigine is approved in the following dosage form: tablet.

Suzetrigine

Brand (NDA) products · tablet

Marketing exclusivity (1)

Listed patents (1)

Suzetrigine — frequently asked questions

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.